Form 4: Kezar Life Sciences Chief Legal Officer Sells Shares to Cover Tax Obligations
SEC Form 4 Filing
Mark C. Schiller, Chief Legal Officer of Kezar Life Sciences, sold 6,688 shares of common stock to cover statutory tax withholding obligations related to vesting restricted stock units.
Summary
- On July 2, 2024, Mark C. Schiller, the Chief Legal Officer of Kezar Life Sciences, sold 6,688 shares of the company's common stock.
- The sale was executed at a price of $0.58 per share.
- This transaction was conducted to cover statutory tax withholding obligations associated with the vesting of restricted stock units.
- Following the transaction, Schiller directly owns 33,007 shares of Kezar Life Sciences stock.
Sentiment
Score: 6
Explanation: The document reflects a routine transaction (sale of shares to cover taxes) and doesn't indicate any significant positive or negative sentiment regarding the company's performance or future prospects.
Management Comments
- The sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of statutory tax withholding obligations to be funded by a 'sell to cover' transaction and does not represent a discretionary sale by the Reporting Person.
Industry Context
Sales of shares to cover tax obligations upon vesting of restricted stock units are a common practice among company executives and employees.
Key Dates
| Date | Description |
|---|---|
| 07/02/2024 | Date of the stock sale transaction. |
| 07/26/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.